The leading source for credible citizen reporting

Report Your News
Take the tour...

Shire Pharmaceutical Cut To Neutral At UBS

Source: Fox News
Madrid : Spain | about 1 month ago  
Views: 0
Shire Pharmaceutical was cut to neutral from buy on Tuesday at UBS, which said there is only limited upside to current share prices. UBS the market has mostly priced in expected earnings from Shire's Velaglucerase, a drug used to treat Gaucher disease.
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Uinta County News | about 1 month ago
    Gaucher disease drug candidate Plicera failed to demonstrate clinically meaningful improvements in key measures of disease in 17 of 18 patients who completed the open-label Phase II study. On a somewhat positive note, the drug did increase the target...
  • News Source: Fox News | about 1 month ago
    Shire Pharmaceutical was cut to neutral from buy on Tuesday at UBS, which said there is only limited upside to current share prices. UBS the market has mostly priced in expected earnings from Shire's Velaglucerase, a drug used to treat Gaucher...
Videos
 >
 
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Cell phones Cell phones use report code: @4319231

Most Popular Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.